The midseason TV lineup holds a lot of promise for new and returning genre shows. The genre I’m interested in is science-fiction, fantasy and horror.
Among returning shows, I’m most excited to watch “The OA” (Netflix), “Marvel’s Cloak and Dagger” (Freeform), “Game of Thrones” (HBO), “The 100” (CW) and “iZombie” (CW).
- “The OA” returns for its second season, which it calls “Part 2,” on March 22.
- “Cloak and Dagger” begins its second season on April 4.
- “Game of Thrones” starts its eighth and final season on April 14.
- “The 100” will premiere its sixth season and the start of “Book Two” on April 30.
- “iZombie” is back for a fifth and final season on May 2.
Of the new shows premiering this season, only “The Passage” (Fox) kept my interest. It’s still on my viewing list, but hasn’t been renewed for a second season yet. (Fingers crossed.) I gave “Manifest” (NBC) a try but found it slow and silly.
Befitting the “peak TV” era, there are lots of new genre shows premiering soon.
Here are several that I want to check out:
- “What We Do in the Shadows” (FX) premieres on March 27. It’s an American comedy series based on the 2014 mockumentary about a group of vampires living together in New Zealand.
- “Osmosis” (Netflix) bows on March 29. Here’s the official synopsis: “Paris, in the near future. Technology has conquered the last frontier: decoding true love. Digging deep into its user’s brain data, the new dating app Osmosis can find a perfect match with 100% accuracy, turning the concept of absolute soulmate into a reality. But is there a price to pay when letting an algorithm decide who you will love, forever and ever?”
- “Hanna” (Amazon Prime Video) premieres on March 29. It is an adaptation of the 2011 movie about a girl raised in the wilderness by her father to be an assassin.
- “Black Summer” (Netflix) launches on April 11. It’s a series set in the “Z Nation” universe, taking place early in the zombie apocalypse.
- “NOS4A2” (AMC), pronounced “Nosferatu,” as in the blood-sucking vampire, premieres on April 30. It’s based on a 2013 novel.
No comments:
Post a Comment